We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

230 hedge funds and large institutions have $1.23B invested in Dynavax Technologies in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 85 increasing their positions, 78 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $5.31M

9% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 78

3% more capital invested

Capital invested by funds: $1.2B → $1.23B (+$33.1M)

0.68% more ownership

Funds ownership: 91.52%92.2% (+0.68%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

3% less funds holding

Funds holding: 236230 (-6)

Holders
230
Holders Change
-6
Holders Change %
-2.54%
% of All Funds
3.7%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
85
Reduced
78
Closed
21
Calls
$10.7M
Puts
$5.31M
Net Calls
+$5.44M
Net Calls Change
+$1.5M
Name Holding Trade Value Shares
Change
Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$8.34M +$581K +50,000 +7%
Principal Financial Group
27
Principal Financial Group
Iowa
$8.3M -$59.4K -5,112 -0.7%
Macquarie Group
28
Macquarie Group
Australia
$8.09M -$11.7K -1,006 -0.1%
GLA
29
Great Lakes Advisors
Illinois
$7.3M -$3.88M -333,693 -33%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$6.88M +$605K +52,070 +9%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$6.63M +$2.03M +174,351 +39%
Nomura Holdings
32
Nomura Holdings
Japan
$6.04M +$425K +36,546 +7%
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$5.85M -$1.34M -115,683 -17%
Lazard Asset Management
34
Lazard Asset Management
New York
$5.65M +$6.05M +520,759 +4,924%
MMA
35
Mizuho Markets Americas
New York
$5.07M +$798K +68,700 +17%
Bank of America
36
Bank of America
North Carolina
$5.07M +$468K +40,292 +9%
Ameriprise
37
Ameriprise
Minnesota
$4.92M -$217K -18,665 -4%
UBS Group
38
UBS Group
Switzerland
$4.58M +$3.61M +311,084 +261%
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$4.41M -$6.25M -537,831 -56%
RA
40
Royce & Associates
New York
$4.31M +$974K +83,840 +26%
Zurich Cantonal Bank
41
Zurich Cantonal Bank
Switzerland
$4.06M -$2.13K -183 -0%
Barclays
42
Barclays
United Kingdom
$4.03M -$213K -18,340 -5%
Citigroup
43
Citigroup
New York
$3.86M -$2.75M -236,734 -39%
Victory Capital Management
44
Victory Capital Management
Texas
$3.8M -$211K -18,199 -5%
Nisa Investment Advisors
45
Nisa Investment Advisors
Missouri
$3.74M +$4.04M +348,000 +9,699%
Thrivent Financial for Lutherans
46
Thrivent Financial for Lutherans
Minnesota
$3.58M +$2.5M +214,961 +177%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$3.44M +$43.5K +3,742 +1%
GC
48
Globeflex Capital
California
$3.27M +$570K +49,067 +19%
Swedbank
49
Swedbank
Sweden
$3.21M
TCM
50
Tang Capital Management
California
$3.19M +$2.32M +200,000 +200%

DVAX Hedge Fund Activity: Q4 2022 in Review

230 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q4 2022, worth a combined $1.23B — up 2.8% from $1.2B a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of DVAX and 19 opened new positions — a net loss of 2 holders — while 78 trimmed existing stakes and 85 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $27M. The largest seller was Bain Capital Life Sciences Investors, cutting an estimated $17.4M.

  • 230 institutional investors held Dynavax Technologies (DVAX) as of Q4 2022, down from 236 in Q3 2022.
  • Funds reported $1.23B of Dynavax Technologies stock for Q4 2022, up 2.8% quarter-over-quarter.
  • 19 funds opened new Dynavax Technologies positions in Q4 2022 and 21 closed out, a net change of -2 holders.
  • The largest Dynavax Technologies buyer in Q4 2022 was Deep Track Capital, an estimated $27M added.
  • The largest Dynavax Technologies seller in Q4 2022 was Bain Capital Life Sciences Investors, an estimated $17.4M sold.

Based on aggregated 13F filings for Q4 2022.